[HTML][HTML] Adherence to and persistence with lacosamide, perampanel, lamotrigine, and levetiracetam in adult patients with focal epilepsy in Japan: a descriptive cohort …
S Chen, T Fukasawa, A Ikeda, M Takeuchi… - Heliyon, 2023 - cell.com
Objective We evaluated adherence to and 1-year persistence of two third-generation anti-
seizure medications (ASMs), lacosamide and perampanel, in adult patients with focal …
seizure medications (ASMs), lacosamide and perampanel, in adult patients with focal …
[HTML][HTML] Evaluation of persistence and healthcare utilization in patients treated with anti-seizure medications as add-on therapy: a nationwide cohort study in South …
JW Lee, JA Kim, MY Kim, SK Lee - Epilepsy & Behavior, 2022 - Elsevier
Objective To compare medication adherence and healthcare utilization among patients who
were treated with anti-seizure medications (ASMs) as first add-on to monotherapy for …
were treated with anti-seizure medications (ASMs) as first add-on to monotherapy for …
[HTML][HTML] Retention rates and successful treatment with antiseizure medications in newly-diagnosed epilepsy patients
S Hwang, H An, DW Shin, HW Lee - Yonsei Medical Journal, 2024 - ncbi.nlm.nih.gov
Purpose Treatment for epilepsy primarily involves antiseizure medications (ASMs), which
can be characterized using the clinical data warehouse (CDW) database. In this study, we …
can be characterized using the clinical data warehouse (CDW) database. In this study, we …
Long-term lacosamide retention—Real-world experience at a tertiary epilepsy center in Ireland
RN McGinty, DJ Costello - Epilepsy & Behavior, 2017 - Elsevier
Purpose To estimate the rate of long-term lacosamide retention among a real-world group of
patients at a tertiary epilepsy center in Ireland. Methods One-hundred adults first prescribed …
patients at a tertiary epilepsy center in Ireland. Methods One-hundred adults first prescribed …
Adjunctive lacosamide treatment for adult focal-onset epilepsy: focus on comorbid intellectual/developmental disorders and differing responses
EA Doğan, U Doğan, E Genç, Ç Erdoğan… - … and Clinical Risk …, 2018 - Taylor & Francis
Background Data regarding lacosamide treatment as an adjunctive therapy in patients
representative of a focal-onset epilepsy population including those with and without …
representative of a focal-onset epilepsy population including those with and without …
Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: a single centre evaluation
J Novy, E Bartolini, GS Bell, JS Duncan, JW Sander - Epilepsy research, 2013 - Elsevier
Lacosamide (LCM) is a recently licensed antiepileptic drug available in the UK since 2008. It
is thought to act through modulation of sodium channel slow inactivation. Its efficacy and …
is thought to act through modulation of sodium channel slow inactivation. Its efficacy and …
[HTML][HTML] Treatment compliance, treatment patterns, and healthcare utilization in epilepsy patients with first add-on antiepileptic drugs: A nationwide cohort study
MY Kim, JA Kim, Y Lee, SK Lee - Heliyon, 2024 - cell.com
Objective This study aimed to assess the treatment compliance, patterns, healthcare
resource utilization (HCRU), and costs of anti-epilepsy drugs (AEDs) as the first add-on …
resource utilization (HCRU), and costs of anti-epilepsy drugs (AEDs) as the first add-on …
Early add-on lacosamide in a real-life setting: results of the REALLY study
V Villanueva, M Garcés, E López-Gomáriz… - Clinical drug …, 2015 - Springer
Background and objectives Many patients with epilepsy are treated with antiepileptic drug
(AED) polytherapy. Several factors influence the choice of early add-on therapy, and …
(AED) polytherapy. Several factors influence the choice of early add-on therapy, and …
A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial‐onset seizures in daily …
U Runge, S Arnold, C Brandt, F Reinhardt, F Kühn… - …, 2015 - Wiley Online Library
Objective Evidence for the efficacy and safety of adjunctive lacosamide in the treatment of
partial‐onset seizures (POS) was gained during placebo‐controlled clinical trials in patients …
partial‐onset seizures (POS) was gained during placebo‐controlled clinical trials in patients …
[HTML][HTML] The influence of demographics and comorbidity on persistence with anti-seizure medication
AD Marshall, JP Pell, A Askarieh, JP Leach, CA Heath - Seizure, 2022 - Elsevier
Purpose To examine the rate of persistence with anti-seizure medications (ASMs) in a cohort
of patients with epilepsy, and to investigate the impact of a range of clinical and …
of patients with epilepsy, and to investigate the impact of a range of clinical and …
相关搜索
- focal epilepsy claims database
- patients with epilepsy safety of lacosamide
- epilepsy patients antiseizure medications
- epilepsy patients treatment compliance
- epilepsy patients retention rates
- epilepsy patients healthcare utilization
- epilepsy patients antiepileptic drugs
- epilepsy patients treatment patterns
- epilepsy patients successful treatment
- monotherapy in patients safety of lacosamide
- patients with epilepsy effectiveness and safety